National

Pro Rata

Axios Pro Rata

Three investment firms with deep health care investing experience are forming a new SPAC that will seek to buy a diagnostics company and take it public, Axios has learned. 

Between the lines: New SPAC formation has slowed, due to a glut of offerings and new SEC scrutiny, but plenty of veteran investors are continuing to jump into the arena.

Details: Venture capital firms ARCH Venture Partners and Section 32 are teaming with Deerfield Management, which invests in both public and private companies.

The SPAC already has filed confidentially for its IPO with the SEC. A publicly-available prospectus is expected within the next month or so. 

Scoop: VC firms file confidentially for biotech SPAC

ARCH Venture Partners, Section 32 and Deerfield have filed confidentially for an IPO.

Illustration of a saline bag solution with money as the liquid in the bag. 

Venture capital

Economy

After a record economic expansion, the coronavirus pandemic sent the U.S. economy into a recession as unemployment soared to staggering heights. The country now faces urgent questions about how much stimulus is needed for reeling consumers and businesses, and what a recovery might look like.

Economy & Business

The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.

Scoop: VC firms file confidentially for biotech SPAC

Go deeper